Drug Profile
VB 210
Alternative Names: VB-210; VITA-210Latest Information Update: 30 Dec 2021
Price :
$50
*
At a glance
- Originator Vitality Biopharma
- Developer Malachite Innovations
- Class Analgesics; Antispastics; Cannabinoids
- Mechanism of Action Cannabinoid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Fibromyalgia; Irritable bowel syndrome; Muscle spasticity; Neuropathic pain
Most Recent Events
- 28 Sep 2020 No recent reports of development identified for preclinical development in Fibromyalgia in USA (IV)
- 28 Sep 2020 No recent reports of development identified for preclinical development in Irritable-bowel-syndrome in USA (PO)
- 28 Sep 2020 No recent reports of development identified for preclinical development in Muscle-spasticity in USA (PO)